You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 130 No. 3, March 1995 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLE
 This Article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Standards for pancreatic resection in the 1990s

C. Fernandez-del Castillo, D. W. Rattner and A. L. Warshaw
Department of Surgery, Massachusetts General Hospital, Boston, Mass.

OBJECTIVE: To describe the current indications and operative outcomes of pancreatic resection. DESIGN: Retrospective case series. SETTING: Referral practice in a university hospital. PATIENTS: Two hundred thirty-one consecutive patients undergoing pancreatoduodenectomy (PD), distal pancreatectomy (DP), or total pancreatectomy (TP) over a 44-month period. Their ages ranged from 16 to 85 years, with a mean of 54 years; 20% of the patients were 70 years old or older. MAIN OUTCOME MEASURES: Mortality, complications, and length of hospital stay. RESULTS: Operative mortality was 0.4% (one death following DP); there were no deaths in 142 PDs or in 18 TPs. The most common complication following PD was delayed gastric emptying. Pancreatic fistula occurred in 6.3% of PD and in 9.8% of DP patients. Overall, 58% of PD, 80% of DP, and 78% of TP patients had no complications. The mean +/- SD length of hospital stay was 15 +/- 7, 10 +/- 5, and 15 +/- 6 days for PD, DP, and TP, respectively. Reoperation for any cause was necessary in only 1.2% (3/231). The most frequent indication for PD was pancreatic cancer (36%) followed by chronic pancreatitis (26%); for DP it was chronic pancreatitis (28%) and cystic neoplasms (27%); and for TP, chronic pancreatitis (55%). Newer indications for pancreatic resection included mucinous ductal ectasia and intraductal papillary tumors (eight cases, 4%) and metastatic tumors (eight cases, 4%). CONCLUSIONS: Current indications for pancreatic resection have expanded. These procedures are associated with a low risk for death and postoperative complications when performed in a high-volume setting.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

DISPACT trial: a randomized controlled trial to compare two different surgical techniques of DIStal PAnCreaTectomy -- study rationale and design
Diener et al.
Clin Trials 2008;5:534-545.
ABSTRACT  

Implications and Management of Pancreatic Fistulas Following Pancreaticoduodenectomy: The Massachusetts General Hospital Experience
Veillette et al.
Arch Surg 2008;143:476-481.
ABSTRACT | FULL TEXT  

Pancreatic Adenocarcinoma: Value of Multidetector CT Angiography in Preoperative Evaluation
Zamboni et al.
Radiology 2007;245:770-778.
ABSTRACT | FULL TEXT  

Extended Resection for Pancreatic Adenocarcinoma
Reddy et al.
The Oncologist 2007;12:654-663.
ABSTRACT | FULL TEXT  

Pancreatic Resection for M1 Pancreatic Ductal Adenocarcinoma
Shrikhande et al.
Ann. Surg. Oncol. 2007;14:118-127.
ABSTRACT | FULL TEXT  

Surgical treatment of pancreatic head carcinoma in elderly patients.
Brozzetti et al.
Arch Surg 2006;141:137-142.
ABSTRACT | FULL TEXT  

Effect of Neoadjuvant Chemoradiation on Operative Mortality and Morbidity for Pancreaticoduodenectomy
Cheng et al.
Ann. Surg. Oncol. 2006;13:66-74.
ABSTRACT | FULL TEXT  

Diagnosis and management of chronic pancreatitis
Gupta and Toskes
Postgrad. Med. J. 2005;81:491-497.
ABSTRACT | FULL TEXT  

Pancreatic Carcinoma in Carriers of a Specific 19 Base Pair Deletion of CDKN2A/p16 (p16-Leiden)
de Vos tot Nederveen Cappel et al.
Clin. Cancer Res. 2003;9:3598-3605.
ABSTRACT | FULL TEXT  

In Situ vs Ex Situ Pancreatic Duct Stents of Duct-to-Mucosa Pancreaticojejunostomy After Pancreaticoduodenectomy With Billroth I-Type Reconstruction
Ohwada et al.
Arch Surg 2002;137:1289-1293.
ABSTRACT | FULL TEXT  

Selection of Pancreaticojejunostomy Techniques According to Pancreatic Texture and Duct Size
Suzuki et al.
Arch Surg 2002;137:1044-1047.
ABSTRACT | FULL TEXT  

Pancreatoduodenectomy for Pancreatic Adenocarcinoma: Triumph, Triumphalism, or Transition?
Bradley III
Arch Surg 2002;137:771-773.
FULL TEXT  

Pancreatic Cancer: Cost-Effectiveness of Imaging Technologies for Assessing Resectability
McMahon et al.
Radiology 2001;221:93-106.
ABSTRACT | FULL TEXT  

Complications after Pancreatoduodenectomy: Imaging and Imaging-guided Interventional Procedures
Gervais et al.
RadioGraphics 2001;21:673-690.
ABSTRACT | FULL TEXT  

Ten-Year Experience With 733 Pancreatic Resections: Changing Indications, Older Patients, and Decreasing Length of Hospitalization
Balcom IV et al.
Arch Surg 2001;136:391-398.
ABSTRACT | FULL TEXT  

Decreasing Length of Stay After Pancreatoduodenectomy
Brooks et al.
Arch Surg 2000;135:823-830.
ABSTRACT | FULL TEXT  

Impact of Laparoscopic Staging in the Treatment of Pancreatic Cancer
Jimenez et al.
Arch Surg 2000;135:409-415.
ABSTRACT | FULL TEXT  

Middle Segment Pancreatectomy: A Novel Technique for Conserving Pancreatic Tissue
Warshaw et al.
Arch Surg 1998;133:327-331.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1995 American Medical Association. All Rights Reserved.